GE Healthcare Collaborates with Imbio on Lung Density Analysis

MINNEAPOLIS: Imbio, a leader in fully automated, biomarker-based solutions for quantitative Lung imaging, and have collaboration to make Imbio's Lung Density Analysis™ . It is a volumetric imaging solution for Lung CT, one of the first software applications to be available in the GE Health Cloud.

As a result of this collaboration, Lung Density Analysis (LDA), Imbio's FDA cleared and CE marked software for quantification and visualization of COPD components, will be fully integrated into GE Health Cloud's clinical workflow. Customers subscribing to LDA through GE Health Cloud will have their CT lung images automatically uploaded for processing with LDA, to receive both an augmented CT lung series with density overlays for detailed image interpretation, as well as patient-friendly summary reports added to their study results.

The full workflow integration will enable streamlined processing to quantify and localize areas of low lung density and air trapping, providing physicians with fast, secure and seamless clinical information to help deliver better patient care. This agreement marks the first step in integrating Imbio's portfolio of lung analysis solutions into the GE Health Cloud.